TREA

98412212 - NOVALIQ

Follow

Information

  • Trademark
  • 98412212
  • Serial Number
    98412212
  • Filing Date
    February 20, 2024
    a year ago
  • Transaction Date
    March 11, 2025
    2 months ago
  • Status Date
    March 11, 2025
    2 months ago
  • Published for Opposition Date
    January 14, 2025
    4 months ago
  • Location Date
    March 11, 2025
    2 months ago
  • Status Code
    688
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    DANG, BAO-NGOC
  • Attorney Docket Number
    NVL23T04US
    Attorney Name
    Natalie Albrecht
    Law Office Assigned Location Code
    L60
  • Owners
Information
Mark Drawing Code
5
Mark Identification
NOVALIQ
Case File Statements
  • DM0000: The mark consists of the wording "NOVALIQ" displayed in stylized characters in blue color.
  • GS0051: Anti-infectives; veterinary pharmaceutical preparations for treatment of ophthalmic disease; pharmaceutical preparations for ophthalmic use; medicinal preparations and pharmaceutical substances for ophthalmic use; liquid and semisolid pharmaceutical compositions for the treatment of eye diseases; eye drops; pharmaceutical preparations for the treatment of the dry eye disease; pharmaceutical preparations for the treatment of ocular surface diseases; pharmaceutical preparations for use in dermatology; medicated preparations for skin treatment; antimicrobials for dermatologic use; anti-dermoinfectives; pharmaceutical preparations for dental use; pharmaceutical preparations for the treatment of posterior eye diseases; pharmaceutical preparations for topical use for treating dermatologic conditions; pharmaceutical water-free preparations (exclusive medicaments, medicines), namely aids in the nature of veterinary pharmaceutical preparations for topical treatment of eye diseases and disorders and active substances comprising semifluorinated alkanes (SFAs) being medical aids.
  • CC0000: The color(s) blue is/are claimed as a feature of the mark.
  • GS0421: Medical and pharmacological research services; scientific research for medical purposes; chemical research and analysis services; scientific laboratory services; development of pharmaceutical preparations and medicines; scientific and technological consultancy relating to the syntheses and production of pharmaceuticals; clinical research in the fields of ophthalmic pharmaceutical preparations, dermatologic pharmaceutical preparations, semifluorinated alkanes (SFAs) and of topical medical treatments; testing, authentication and quality control for others in the field of semifluorinated alkanes (SFAs) and of water-free pharmaceutical preparations.
Case File Event Statements
  • 2/20/2024 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 2/23/2024 - a year ago
    2 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 6/25/2024 - 10 months ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/10/2024 - 8 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/19/2024 - 7 months ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/19/2024 - 7 months ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/19/2024 - 7 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/18/2024 - 4 months ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/18/2024 - 4 months ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/18/2024 - 4 months ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/19/2024 - 4 months ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/8/2025 - 4 months ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/14/2025 - 4 months ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/14/2025 - 4 months ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/11/2025 - 2 months ago
    15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM